Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Elixirr International Plc ( (GB:ELIX) ).
Elixirr International has issued 822,194 new ordinary shares to satisfy the equity component of contingent consideration tied to the 2025 performance of its acquired U.S. advisory firm TRC Advisory, valuing the issuance at £5.9 million. The new shares, subject to a one-year lock-in and phased sale limits, underscore Elixirr’s continued use of equity to fund acquisitions and align incentives as it integrates TRC and consolidates its presence as a growth-focused consultancy.
The company is seeking admission of these shares to the Financial Conduct Authority’s Official List and trading on the London Stock Exchange’s Main Market, where they will rank pari passu with existing stock. Following admission, Elixirr’s total share count and voting rights will rise to 50,853,348, a change shareholders must factor into regulatory disclosure calculations regarding their holdings under UK transparency rules.
The most recent analyst rating on (GB:ELIX) stock is a Buy with a £1060.00 price target. To see the full list of analyst forecasts on Elixirr International Plc stock, see the GB:ELIX Stock Forecast page.
Spark’s Take on ELIX Stock
According to Spark, TipRanks’ AI Analyst, ELIX is a Outperform.
The score is driven primarily by strong financial fundamentals (scaled revenue, healthy margins, solid returns), tempered by increased 2025 leverage and weaker operating cash support. Technicals are supportive with positive momentum but show near-term overbought risk and lingering overhead versus the 200-day average. Valuation is reasonable but not notably cheap, and the dividend yield is modest.
To see Spark’s full report on ELIX stock, click here.
More about Elixirr International Plc
Elixirr International plc is an award-winning global consulting firm that positions itself as a challenger to traditional large consultancies, working with clients across multiple industries and geographies. Founded in 2009 and listed on London’s Main Market since 2025, it has expanded through organic growth and nine boutique acquisitions to broaden capabilities, diversify services and enter new markets.
Average Trading Volume: 182,212
Technical Sentiment Signal: Buy
Current Market Cap: £356.5M
See more insights into ELIX stock on TipRanks’ Stock Analysis page.